Answers are grounded in this paper and cite their sources.
Mouse knockout study reveals severe osteoporosis and arterial calcification in osteoprotegerin-deficient mice, indicating a shared molecular pathway between bone loss and vascular disease.
Osteoprotegerin (OPG) is a secreted protein that inhibits osteoclast formation. In this study the physiological role of OPG is investigated by generating OPG-deficient mice. Adolescent and adult OPG-/- mice exhibit a decrease in total bone density characterized by severe trabecular and cortical bone porosity, marked thinning of the parietal bones of the skull, and a high incidence of fractures. These findings demonstrate that OPG is a critical regulator of postnatal bone mass. Unexpectedly, OPG-deficient mice also exhibit medial calcification of the aorta and renal arteries, suggesting that regulation of OPG, its signaling pathway, or its ligand(s) may play a role in the long observed association between osteoporosis and vascular calcification.
No takes yet. Share an insight, caveat, or question.
Bucay et al. (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: